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Osteoblast-derived extracellular vesicles (EV) are a collection of secreted (sEVs) and
matrix-bound nanoparticles that function as foci for mineral nucleation and accumulation.
Due to the fact sEVs can be isolated directly from the culture medium of mineralizing
osteoblasts, there is growing interest their application regenerative medicine. However,
at present therapeutic advancements are hindered by a lack of understanding of their
precise temporal contribution to matrix mineralization. This study advances current
knowledge by temporally aligning sEV profile and protein content with mineralization
status. sEVs were isolated from mineralizing primary osteoblasts over a period of 1,
2, and 3 weeks. Bimodal particle distributions were observed (weeks 1 and 3: 44
and 164 nm; week 2: 59 and 220 nm), indicating a heterogeneous population with
dimensions characteristic of exosome- (44 and 59 nm) and microvesicle-like (164 and
220 nm) particles. Proteomic characterization by liquid chromatography tandem-mass
spectrometry (LC-MS/MS) revealed a declining correlation in EV-localized proteins as
mineralization advanced, with Pearson correlation-coefficients of 0.79 (week 1 vs. 2),
0.6 (2 vs. 3) and 0.46 (1 vs. 3), respectively. Principal component analysis (PCA)
further highlighted a time-dependent divergence in protein content as mineralization
advanced. The most significant variations were observed at week 3, with a significant
(p < 0.05) decline in particle concentration, visual evidence of EV rupture and enhanced
mineralization. A total of 116 vesicle-localized proteins were significantly upregulated at
week 3 (56% non-specifically, 19% relative to week 1, 25% relative to week 2). Gene
ontology enrichment analysis of these proteins highlighted overrepresentation of genes
associated withmatrix organization. Of note, increased presence of phospholipid-binding
and calcium channeling annexin proteins (A2, A5, and A6) indicative of progressive
variations in the nucleational capacity of vesicles, as well as interaction with the
surrounding ECM. We demonstrate sEV-mediated mineralization is dynamic process
with variations in vesicle morphology and protein content having a potential influence
on developmental changes matrix organization. These findings have implications for the
selection and application of EVs for regenerative applications.
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INTRODUCTION
Bone formation is a carefully orchestrated and well-regulated
process whereby inorganic mineral is deposited on a collagenous
matrix. Early mineral deposition is principally coordinated by
osteoblasts, which modulate local phosphate ion concentrations
and drive osteogenesis. Despite significant advancement
in musculoskeletal biology, current understanding of the
processes by which mineral is first deposited and propagated
within the extracellular matrix (ECM) remain incompletely
understood (Boskey, 1998). Early studies postulated that matrix
mineralization was largely a passive and cell-independent
process whereby non-collagenous proteins confined to gap zones
function as sites for the localization of ions that drive mineral
nucleation (Bonucci, 2012). However, two highly significant
ultrastructural studies published in 1967 identified the active
contribution of nano-sized extracellular vesicles (EVs, 50–
400 nm), which functioned as loci for early mineral nucleation
and propagation in growth plate cartilage (Anderson, 1967;
Bonucci, 1967). It was subsequently demonstrated that mineral
crystallized in and around EVs, forming the spheroidal nodules
characteristic of mineralization both in vitro and in vivo. It
has since been shown that these particles are released into the
developing ECM where they determine the specific and localized
pattern of nodular mineralization observed in developing bones
(Anderson, 1995). Mature nodules then fuse to generate seams
of woven bone (Marvaso and Bernard, 1977). Recent evidence
suggests that this process is dynamic, progressing from an initial
amorphous phase through a series of precursors and that this
transition is, in part, facilitated by EVs (Mahamid et al., 2010).
Since these initial studies, EVs have been identified in a
wide range of tissues and biofluids. This has resulted in the
establishment of the International Society for Extracellular
Vesicles (ISEV) and the subsequent publication of position
statements outlining criteria for defining these complex bioactive
nanoparticles (Théry et al., 2019). However, advancement in
vesicle biology and nomenclature has largely occurred in
parallel to developments in bone matrix biology. Vesicles
identified within the extracellular matrix of bone are routinely
defined matrix vesicles (MV) with a size distribution ranging
from 50–400 nm. Aligning this definition with current vesicle
nomenclature, it would be reasonable to hypothesize that
these vesicles comprise a heterogeneous mixture of exosomes
(30–150 nm) and microvesicles (100–500 nm) that may have
divergent roles in directing mineralization and intercellular
communication in developing bone (Shapiro et al., 2015).
Furthermore, it is now understood that in addition to matrix-
associated vesicles, osteoblasts cultured in vitro also generate
a population of secreted vesicles that can be isolated the
surrounding culture medium (Nair et al., 2014; Davies et al.,
2017). We have previously demonstrated that these secreted
EVs (sEVs) are enriched in annexin calcium-binding proteins
and that the exogenous delivery of these bioactive particles can
significantly enhance osteogenesis in mesenchymal stem cell
(MSC) cultures (Davies et al., 2017). However, if these pro-
osteogenic sEVs are to be applied therapeutically additional
work is required to define how their properties vary over
the course of mineralization and better understand how their
properties align with the more comprehensively characterized
MVs (Shapiro et al., 2015).
Vesicles derived from different tissue sources are uniquely
adapted to fulfill the requirements of that tissue. As such, vesicles
will contain specific protein, lipid and nucleic acid signatures
indicative of their tissue of origin. Within developing bone,
osteoblast-derived vesicles have been shown to function in early
mineralization events preceding endochondral ossification. To
fulfill their function, these particles are enriched in membrane
lipids (e.g., cholesterol, sphingomyelin and phosphatidylserine),
calcium binding proteins (e.g., annexins-A1, -A2,−5, and –
A6) and phosphate converting enzymes (e.g., tissue non-specific
alkaline phosphatase, TNAP, and nucleotide pyrophosphatase
phosphodiesterase, Enpp) (Kirsch et al., 2000; Davies et al.,
2017). Together this specialized collection of lipids and
proteins comprises the nucleational-core-complex (NCC), which
facilitates the uptake, binding and organization of calcium and
phosphate ions to initiate mineral formation, expansion and
crystallization (Wu et al., 1993). It is proposed that EVs bud
from the osteoblast plasma membrane and accumulate calcium
and phosphate ions extracellularly, providing an optimized niche
for the transition to crystalline apatite that eventually ruptures
the vesicle and is deposited on the collagenous ECM (Davies
et al., 2017; Hasegawa et al., 2017). Additionally, internal sources
of polyphosphate, such as ATP, are also considered to play a
significant role in coordinating osteogenesis both as a source
of inorganic phosphate and through their action on purinergic
signaling pathways (Orriss et al., 2013). However, much of the
data surrounding existing theory has been collected in studies of
matrix-bound vesicles, where MVs have been digested from the
collagenous matrix (Bottini et al., 2018). Consequently, limited
information exists regarding the precise temporal contribution
of sEVs to matrix mineralization. Since the production and
isolation of sEVs is less laborious and time-consuming than MVs
they present an appealing source of particles for regenerative
applications and investment is required to comprehensively
characterize their temporal roles in matrix mineralization.
To date, we and others have documented the capacity of
vesicles isolated from the media of differentiating osteoblasts to
function as sites of nucleation within mineralizing tissues and
have begun to define a mechanism of action based on their
biological content (Davies et al., 2017). However, if we are to fully
understand their contribution to hard tissue matrix development
and potentially exploit these bioactive particles to enhance bone
regeneration it is essential that we begin to understand how
their function changes over the course of mineralization. In
this study we morphologically and proteomically characterize
vesicles secreted by primary human osteoblasts under defined
culture conditions during mineralization in order to define their
temporal effects during osteogenesis.
MATERIALS AND METHODS
Primary Osteoblast Isolation and Culture
This study was approved by the University of Birmingham UK
Research Ethics Committee (Reference: 16/SS/0172). Written
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informed consent was obtained from all participants. Human
osteoblast cells were obtained from donated human bone
following joint replacement surgeries and all experiments
were carried out in triplicate using cells derived from three
independent donors. Cartilage was removed from the femoral
condyles and tibial plateaux. The exposed trabecular bone was cut
into small chips of ∼2 mm3. To remove contaminating adipose,
chips were washed 3 times in 30mL mineralization media
(MM) comprising of minimal essential media α modification
(α-MEM) (Sigma-Aldrich, UK) supplemented with 10%
fetal bovine serum (FBS), 100 units/mL penicillin (Sigma-
Aldrich, UK), 100µg/mL streptomycin (Sigma-Aldrich, UK),
2mM L-glutamine (Sigma-Aldrich, UK), 1% non-essential
amino acids (Invitrogen, UK), 2mM β-glycerophosphate
(Sigma-Aldrich, UK), 50µg/mL ascorbic acid (Sigma-Aldrich,
UK), 10 nM dexamethasone (Sigma-Aldrich, UK). Chips
were then placed into a T125 culture flask (Nunc, UK) with
fresh MM and cultured, replacing media every 3–4 days,
to encourage outgrowth of osteoblasts. Bone chips were
removed after 10–14 days and remaining osteoblasts were
cultured, typically reaching confluence after 21 days, at which
point the cells were passaged. Non-mineralizing controls
were cultured in growth medium (GM) that comprised of
minimal essential media α modification (α-MEM) (Sigma-
Aldrich, UK) supplemented with 10% fetal bovine serum (FBS),
100 units/mL penicillin (Sigma-Aldrich, UK), 100µg/mL
streptomycin (Sigma-Aldrich, UK), 2mM L-glutamine
(Sigma-Aldrich, UK) and 1% non-essential amino acids
(Invitrogen, UK).
qRT-PCR Quantification of Gene
Expression
Comparative expression of osteogenic marker genes was
evaluated in osteoblast isolated from three independent donors
to asses variability between donors. Bone chips were washed
in sterile PBS before being snap frozen in liquid nitrogen.
They were then powdered using a cryogenic grinder (6775
Freezer Mill, SPEX SamplePrep, Stanmore, UK) before RNA
isolation using TRIzol reagent (ThermoFisher, UK). Briefly, 1mL
TRIzol reagent was added to 100mg of powdered tissue and
homogenized using a TissueRuptor (Qiagen, UK). Chloroform
was added to separate the RNA from the DNA and protein
phases. The RNA was then precipitated using isopropanol
overnight at −20◦C. The precipitated RNA was centrifuged,
and the pellet washed with 70% ethanol before drying and
then resuspending in RNAse-free water. The concentration
and quality of RNA was verified using the Nanodrop 2000
(ThermoFisher, UK). 260/280 ratios of >1.8 were deemed
suitable for PCR analysis.
For qRT-PCR, OneStepPLUS SYBR Green master mix,
custom primers (sequences provided in Table 1) and the
housekeeping gene (B-actin) were designed and made
by PrimerDesign (Southampton, UK). PCR was run on
a BioRadCFX384 for 50 amplification cycles before the
relative expression of each gene was calculated using the
ddCT method.
Isolation of Secreted Extracellular Vesicles
Primary human osteoblasts isolated from three independent
donors were cultured at passage 2 for a total period of 21
days. Cell culture medium incorporated FBS that has been
ultracentrifuged at 120,000 × g for a period of 18 h to deplete
any naturally occurring vesicles that may compromise the
quality of downstream analyses (Shelke et al., 2014). sEVs
were isolated from primary human every 2–3 days and pooled
into three respective groups: week 1, 2, and 3. Cells and
cellular debris was removed by centrifuging each sample at
2000 × g for 30min. Five millilitre of the supernatant was
carefully transferred to a sterile polycarbonate ultracentrifuge
tubes (Beckman Coulter, UK) containing 2.5mL commercial
total exosome isolation reagent (ThermoFisher, UK). The
solution was mixed thoroughly and incubated at 4◦C to
allow for sEV precipitation. Following incubation, the samples
were transferred to an Avanti J-26S XPI high performance
centrifuge (Beckman Coulter, UK) and spun at 10,000 × g
for 60min at 4◦C in line with the manufacturer’s guidelines.
The supernatant was discarded, and each pellet resuspended
in 300 µL filtered PBS. Fifty microliter were stored at −80◦C
before analysis.
sEV Sizing and Quantitation
Total protein concentration was determined using the Pierce
BCA protein assay kit (ThermoFisher, UK) and confirmed by
Nanodrop spectrophotometry (ThermoFisher, UK). Particle
concentration was determined using a Nanosight LM10
(Malvern Panalytical, UK) and size distribution analyzed
by Dynamic Light Scattering using the Zetasizer HPPS
(Malvern Panalytical, UK). All experiments were carried out
in triplicate.
Transmission Electron Microscopy
A suspension of sEVs was made in sterile filtered PBS. A single
drop of the suspension (∼20 µL) was deposited onto a carbon
film grid (Agar Scientific, UK) and left to air dry for a period
of 1min. To remove excess PBS the grid was gently blotted
using tissue paper through capillary action. Negative staining was
achieved by placing a single drop (∼20 µL) of uranyl acetate
solution onto the dry grid. Samples were imaged using a JEM
3200FX transmission electron microscope (Joel, USA) using a
voltage of 80 kV.
Alkaline Phosphatase Assay
Cellular ALP levels were quantified using the SensoLyte R© pNPP
Alkaline Phosphatase Assay Kit (Anaspec, UK) according to
the manufacturer’s instructions. Briefly, cell monolayers were
washed twice using 1x assay buffer provided. Cells were detached
from the surface of the culture plate in the presence of 200 µL
permeabilization buffer using a cell scraper. The resulting cell
suspension was collected in a microcentrifuge tube, incubated
at 4◦C for 10min under agitation, and then centrifuged at 2500
× g for 10min. Supernatant was transferred to a 96 well plate
where it was combined with an equal volume of pNPP substrate.
Absorbance was measured at 405 nm using a plate reader. ALP
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TABLE 1 | Primer sequences and accompanying gene accession numbers.
Gene Forward Reverse Accession No.
ALP CTTGGGCAGGCAGAGAGTA AGTGGGAGGGTCAGGAGAT NM_000478
BGLAP GGCACCCTTCTTTCCTCTTC TTCTGGAGTTTATTTGGGAGCA NM_199173
BSP GAGGTGATAGTGTGGTTTATGGA TGATGTCCTCGTCTGTAGCA NM_00104005
COL1A1 AGACAGTGATTGAATACAAAACCA GGAGTTTACAGGAAGCAGACA NM_000088
levels were normalized to cell number, which was determined
using Trypan blue cell counting.
Alizarin Red Staining and Quantification
Human osteoblast cultures were incubated for a period of 21
days in MM, with medium changes performed every 2–3 days.
Calcium-rich deposits were visualized using 40mM alizarin red
(AR - Sigma-Aldrich, UK) stain, which was dissolved in acetic
acid and adjusted to pH 4.2 using 5M ammonium hydroxide.
Bound AR was quantified through acetic acid extraction
and colorimetric detection at 405 nm. AR concentration were
normalized to cell number, which was determined using Trypan
blue cell counting.
Mass Spectrometry
Mass spectrometry analysis was performed on sEVs isolated
from three separate donors. Each was analyzed in triplicate to
limit technical variation. sEV proteins were digested by FASP
with LysC and trypsin as described previously (Wisniewski
et al., 2009). The peptides generated were then separated by
nano-flow reversed-phase liquid chromatography coupled to
Q Exactive Hybrid Quadrupole-Orbitrap mass spectrometer
(Thermo Scientific, UK). Peptides were loaded on a C18
PepMap100 pre-column (300µm I.D.× 5mm, 3µm C18 beads;
Thermo Scientific) and separated on a 50 cm reversed-phase
C18 column (75µm I. D., 2µm C18 beads). Separation was
conducted with a linear gradient of 7–30% B 120min at a
flow rate of 200 nL/min (A: 0.1% formic acid, B: 0.1% formic
acid in acetonitrile). All data was acquired in a data-dependent
mode, automatically switching from MS to collision-induced
dissociation MS/MS on the top 10 most abundant ions with a
precursor scan range of 350–1650 m/z. MS spectra were acquired
at a resolution of 70,000 and MS/MS scans at 17,000. Dynamic
exclusion was enabled with an exclusion duration of 40 s. The raw
data files generated were processed using the MaxQuant (version
1.5.0.35) software, integrated with the Andromeda search engine
as described previously (Cox and Mann, 2008; Cox et al., 2011).
Resulting MS/MS spectra were searched against the human
proteome (UniProt 2013/04/03), precursor mass tolerance was
set to 20 ppm, variable modifications defined as acetylation
(protein N-terminus) and oxidation (M), carbamidomethylation
(C) was defined as fixed modification. Enzyme specificity was set
to trypsin with a maximum of 2 missed cleavages. Protein and
peptide spectral matches (PSM) false discovery rate (FDR) was
set at 0.01 and match between runs was applied. Finally, only
proteins identified in 2 biological replicates with a minimum of
2 spectral counts (SC) in one biological replicate were included
for analysis. For proteins to be considered specific to a particular
fraction they must have exhibited combined SC ≥ 5.
Differential protein abundance analysis was performed with
Perseus (version 1.5.5.3). In brief, Log2-transformed protein
intensity distributions were median-normalized and a t-test was
used to assess the statistical significance of protein abundance
fold-changes. P-values were adjusted for multiple hypothesis
testing with the Benjamini-Hochberg correction (Hochberg and
Benjamini, 1990).
Multivariate Statistics to Highlight
Candidate Proteins
Multivariate analyses were performed using SIMCA (v14.1,
MKS Umetrics AB, Umeå, Sweden). Protein abundances
were Log2-transformed, median-normalized and an arbitrary
minimum value assigned to instances where the measured
protein intensity was zero. All data were Pareto scaled prior
to analyses. Initially, an unsupervised principal components
analysis (PCA) was performed on all measured proteins and
a 3-dimensional score plot produced to visualize the profile
of each experimental arm (weeks 1, 2, and 3). In addition,
supervised analyses were performed using orthogonal partial
least squares-discriminate analyses (OPLS-DA) to investigate
between-group differences in protein profiles for weeks 1 vs. 2,
1 vs. 3 and 2 vs. 3. Peptides considered as major contributors to
the separation of sample groupings were identified by assessing
the relevant S-plot.
Bioinformatic Analysis
The protein annotation through evolutionary relationship
(PANTHER, http://www.pantherdb.org/) classification system
(version 9.0) was used for gene ontology (GO) annotation
of biological pathways, molecular mechanisms and cellular
compartments of proteins.
Data Analysis and Statistics
T-Tests and ANOVA statistical analyses were performed using
MiniTAB R© v.16 (MiniTAB Inc., State College, PA, USA). p< 0.05
were defined as statistically significance.
RESULTS
Primary human osteoblasts were isolated from trabecular bone
obtained during elective hip arthroplasty surgeries (UK National
Research Ethics Committee Reference: 16/SS/0172). Isolated
osteoblasts were characterized prior to expansion for the
expression of genes indicative of phenotype. All four genes
(Col1A1, BGLAP, ALP, and BSP) were shown to be upregulated
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TABLE 2 | Proteins identified as exclusive to or significantly upregulated in sEVs isolated from the culture medium of human osteoblasts derived from three separate
donors during the third week of mineralization.
Gene name UniProt ID Protein name Week 1a Week 2a Week 3a Week 1b Week 2b Week 3b
UPREGULATED IN WEEK 3
NT5E P21589 5-nucleotidase 20.3 25.2 27.9 0 2 5
YWHAE P62258 14-3-3 protein epsilon 19.6 22.0 25.4 1 1 1
MMP2 P08253 72 kDa type IV collagenase 30.3 31.2 32.7 15 16 23
ANPEP P15144 Aminopeptidase N 24.8 28.6 30.9 3 12 14
ANXA2 P07355 Annexin A2 29.5 30.4 32.3 12 15 17
ANXA6 P08133 Annexin A6 18.0 18.0 26.5 0 0 3
APOC3 P02656 Apolipoprotein C-III 20.7 23.3 30.0 0 1 1
APOE P02649 Apolipoprotein E 22.4 18.0 26.5 4 3 7
BSG P35613 Basigin 18.0 18.0 24.2 0 0 1
CAV1 Q03135 Caveolin-1 18.0 18.0 25.0 0 0 1
CPM P14384 Carboxypeptidase M 18.0 18.0 24.7 0 0 1
CTSD P07339 Cathepsin D 18.0 22.3 24.9 0 0 1
CD44 P16070 CD44 antigen 25.4 26.0 27.2 74 45 87
CD59 P13987 CD59 glycoprotein 25.2 20.0 26.8 1 0 1
CHI3L1 P36222 Chitinase-3-like protein 1 25.4 28.8 30.0 2 8 9
COPB2 P35606 Coatomer subunit beta 18.0 18.0 24.6 0 0 2
COL6A1 P12109 Collagen alpha-1(VI) chain 33.8 34.4 35.6 29 32 33
COL6A3 P12111 Collagen alpha-3(VI) chain 35.7 35.1 37.0 119 108 131
C1QTNF1 Q9BXJ1 Complement C1q tumor necrosis
factor-related protein 1
18.0 18.0 24.6 0 0 1
CXCL6 P80162 C-X-C motif chemokine 6 26.6 27.9 30.3 3 5 5
DCN P07585 Decorin 33.6 33.4 34.5 14 14 17
EEF1G P26641 Elongation factor 1-gamma 22.4 20.1 25.4 1 0 1
EIF4A1 P60842 Eukaryotic initiation factor 4A-I 26.8 25.8 26.2 1 0 2
FSCN1 Q16658 Fascin 20.4 19.6 24.3 0 0 1
FTH1 P02794 Ferritin heavy chain 26.1 26.4 28.0 1 2 3
FIBIN Q8TAL6 Fin bud initiation factor homolog 20.4 18.0 24.2 0 0 1
LGALS1 P09382 Galectin-1 20.4 26.5 29.3 0 3 4
GSN P06396-2 Gelsolin 22.1 20.2 24.3 1 1 1
SERPINE2 P07093-2 Glia-derived nexin 31.2 31.2 33.1 0 0 1
GDF6 Q6KF10 Growth/differentiation factor 6 21.2 18.0 25.1 1 0 1
GNB2 P62879 Guanine nucleotide-binding protein
G(I)/G(S)/G(T) subunit beta-2
18.0 22.6 24.1 0 1 2
ISLR O14498 Immunoglobulin superfamily containing
leucine-rich repeat protein
20.5 21.8 24.6 0 1 1
KPNB1 Q14974 Importin subunit beta-1 22.6 18.0 26.2 1 0 1
PAMR1 Q6UXH9 Inactive serine protease PAMR1 18.0 19.9 26.4 0 0 2
IGFBP2 P18065 Insulin-like growth factor-binding protein 2 26.1 26.9 28.4 9 9 10
ITGAV P06756 Integrin alpha-V 19.6 18.0 24.4 0 0 1
KATNAL2 Q8IYT4 Katanin p60 ATPase-containing subunit
A-like 2
18.0 19.9 24.9 0 0 1
LAMA1 P25391 Laminin subunit alpha-1 25.4 26.1 27.3 2 2 4
LAMA4 Q16363 Laminin subunit alpha-4 31.0 31.3 32.8 26 28 40
LAMB1 P07942 Laminin subunit beta-1 31.7 32.6 34.0 40 46 58
LUM P51884 Lumican 19.9 22.9 25.8 0 1 1
MAMDC2 Q7Z304 MAM domain-containing protein 2 20.4 20.3 26.7 0 0 4
MFAP2 P55001 Microfibrillar-associated protein 2 18.0 20.0 24.5 0 0 1
NEO1 Q92859 Neogenin 21.9 18.0 23.6 1 0 1
GANAB Q14697 Neutral alpha-glucosidase AB 19.7 18.0 25.3 0 0 2
NME2 P22392 Nucleoside diphosphate kinase B 20.7 20.0 22.4 0 0 2
(Continued)
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TABLE 2 | Continued
Gene name UniProt ID Protein name Week 1a Week 2a Week 3a Week 1b Week 2b Week 3b
PAPPA Q13219 Pappalysin-1 28.9 28.8 32.0 14 12 31
PXDN Q92626 Peroxidasin homolog 32.6 32.4 33.7 49 48 58
PDGFD Q9GZP0 Platelet-derived growth factor D 20.3 22.9 28.0 0 1 5
PLEC Q15149 Plectin 19.7 27.1 30.0 1 8 28
PFN1 P07737 Profilin-1 18.0 19.8 24.8 0 0 1
PDIA3 P30101 Protein disulfide-isomerase A3 20.3 18.0 22.2 0 0 1
S100A10 P60903 Protein S100-A10 19.4 18.0 25.4 0 0 1
SEC23A Q15436 Protein transport protein Sec23A 18.0 18.0 26.2 0 0 2
7WNT5A P41221 Protein Wnt-5a 27.4 28.3 30.8 4 5 9
PTPRD P23468 Receptor-type-tyrosine-protein
phosphatase delta
20.9 18.0 23.2 0 0 1
SPTAN1 Q13813 Spectrin alpha chain, non-erythrocytic 1 25.1 25.9 28.6 4 4 12
SPTBN1 Q01082 Spectrin beta chain, non-erythrocytic 1 24.7 25.3 28.9 2 2 11
SPON1 Q9HCB6 Spondin-1 21.1 20.3 28.8 0 0 5
STC1 P52823 Stanniocalcin-1 27.4 26.2 29.0 2 2 3
STC2 O76061 Stanniocalcin-2 26.2 26.6 28.6 2 2 4
SRPX P78539-5 Sushi repeat-containing protein SRPX 26.6 26.5 29.6 4 3 9
VCP P55072 Transitional endoplasmic reticulum ATPase 19.4 20.4 29.2 0 1 8
TNFAIP6 P98066 Tumor necrosis factor-inducible gene 6
protein
28.4 28.6 30.7 8 7 11
DIFFERENTIALLY UPREGULATED RELATIVE TO WEEK 1
ACTR3 P61158 Actin-related protein 3 28.16 28.5 29.6 6 6 7
ARPC1B O15143 Actin-related protein 2/3 complex subunit
1B
25.1 25.7 26.6 2 2 3
ENO1 P06733 Alpha-enolase 27.4 27.5 28.6 3 4 6
ANXA5 P08758 Annexin A5 24.5 26.4 28.8 1 5 7
AP2B1 P63010 AP-2 complex subunit beta 21.1 22.9 25.0 1 1 2
28CLTC Q00610 Clathrin heavy chain 1 22.8 26.0 28.1 1 4 7
C1S P09871 Complement C1s subcomponent 31.2 31.8 32.6 19 20 21
CXCL5 P42830 C-X-C motif chemokine 5 23.3 25.8 28.1 1 2 3
ART4 Q93070 Ecto-ADP-ribosyltransferase 4 18.0 25.7 25.3 0 1 1
6F7TL P02792 Ferritin light chain 18.0 25.7 26.9 0 1 2
FN1 P02751 Fibronectin 38.9 39.5 40.0 138 149 160
LGALS3BP Q08380 Galectin-3-binding protein 25.1 26.2 28.1 2 3 5
PYGB P11216 Glycogen phosphorylase 24.1 25.4 26.9 1 2 2
GVINP1 Q7Z2Y8 Interferon-induced very large GTPase 1 22.6 25.2 26.3 1 1 1
LAMA2 P24043 Laminin subunit alpha-2 32.0 33.0 33.9 59 73 89
LAMC1 P11047 Laminin subunit gamma-1 32.6 33.3 34.2 46 52 58
S100A6 P06703 Protein S100-A6 24.9 26.6 27.9 1 1 2
CXCL12 P48061 Stromal cell-derived factor 1 18.0 21.5 25.7 0 1 1
TFPI P10646 Tissue factor pathway inhibitor 22.5 20.0 22.7 1 0 1
TPI1 P60174 Triosephosphate isomerase 18.0 18.0 24.6 0 0 1
UCN3 Q969E3 Urocortin-3 18.0 18.0 24.9 0 0 1
VIM P08670 Vimentin 29.1 30.2 32.0 9 14 20
DIFFERENTIALLY UPREGULATED RELATIVE TO WEEK 2
ANGPT1 Q15389 Angiopoietin-1 28.3 28.2 29.5 6 7 8
AP2A1 O95782 AP-2 complex subunit alpha-1 22.3 18.0 25.6 1 0 2
APOD P05090 Apolipoprotein D 30.2 25.6 31.0 6 4 6
HSPG2 P98160 Basement membrane-specific heparan
sulfate proteoglycan core protein
32.2 30.7 32.7 53 28 57
COL12A1 Q99715 Collagen alpha-1(XII) chain 32.4 30.9 33.6 74 45 87
(Continued)
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TABLE 2 | Continued
Gene name UniProt ID Protein name Week 1a Week 2a Week 3a Week 1b Week 2b Week 3b
COL16A1 Q07092 Collagen alpha-1(XVI) chain 25.5 19.7 25.1 2 0 2
EEF1A1 P68104 Elongation factor 1-alpha 1 27.5 27.5 29.1 4 3 6
EEF2 P13639 Elongation factor 2 27.7 27.3 28.5 8 6 9
EMILIN1 Q9Y6C2 EMILIN-1 28.7 29.3 30.8 11 13 18
CXCL1 P09341 Growth-regulated alpha protein 26.5 26.4 28.3 2 1 3
PYGB P11216 Glycogen phosphorylase 25.4 24.1 26.9 2 2 2
SPON1 Q9HCB6 Spondin-1 21.1 20.3 28.8 22 12 23
FBN1 P35555 Fibrillin-1 33.3 31.7 33.4 48 32 52
FBN2 P35556 Fibrillin-2 33.2 31.1 32.6 53 32 46
GAS6 Q14393-3 Growth arrest-specific protein 6 29.9 29.4 26.9 11 10 4
HOXC10 Q9NYD6 Homeobox protein Hox-C10 30.5 31.6 33.9 1 1 1
MYH9 P35579 Myosin-9 28.1 26.5 29.0 7 3 9
GANAB Q14697 Neutral alpha-glucosidase AB 19.7 18.0 25.3 11 13 18
NID2 Q14112 Nidogen-2 31.0 29.1 32.0 22 12 24
PGM1 P36871 Phosphoglucomutase-1 26.6 25.0 26.7 3 2 4
PCOLCE2 Q9UKZ9 Procollagen C-endopeptidase enhancer 2 27.0 25.0 26.8 3 2 3
PKM P14618 Pyruvate kinase PKM 30.5 29.5 30.8 11 10 14
QSOX1 O00391 Sulfhydryl oxidase 1 27.8 27.1 29.0 5 6 8
SOD2 P04179 Superoxide dismutase 27.3 28.0 30.8 1 1 2
SNED1 Q8TER0 Sushi, nidogen and EGF-like
domain-containing protein 1
26.0 25.6 27.8 4 3 7
THBS1 P07996 Thrombospondin-1 36.4 35.3 37.2 20 15 21
TGFBI Q15582 Transforming growth factor beta-induced
protein ig-h3
32.1 31.1 32.8 2 1 16
TUBB4B P68371 Tubulin beta-4b chain 22.1 19.8 23.6 2 1 3
WISP2 O76076 WNT1-inducible-signaling pathway protein
2
23.1 26.1 29.1 2 1 4
The table presents proteins significantly upregulated in sEVs isolated at week 3 when compared to weeks 1 and 2.
a represents the average number of unique peptides identified in three biological repeats.
b represents the average log(2) transformed signal intensity.
For a full list of proteins identified in the study please see Supplementary Table 1.
Full accompanying statistical data can be found in Supplementary Table 2.
when compared with a baseline housekeeping gene, GAPDH
(Figure 1A). The presence of calcium deposition within the
developing matrix was observed using alizarin red (AR) staining
(Figure 1B). Visualization and quantification of AR staining
revealed that mineral deposition was limited in day 7 cultures
but showed statistical significance (p < 0.05) when compared
with non-osteogenic controls at days 14 (8.32-fold increase)
and 21 (6.43-fold increase) (Figure 1C). The expression of the
pyrophosphate hydrolysing enzyme alkaline phosphatase (ALP)
was significantly increased (p < 0.05) at day 7 and 14 when
compared with the control (Figure 1D), further confirming
induction of differentiation and mineralization in primary
osteoblast cultures.
We have previously shown that sEVs function as sites of
mineral nucleation in developing matrix. However, there is
currently little understanding of how the contribution of these
particles changes as cells progress from an immature to a mature
state. To begin to answer this question we isolated sEVs from
the culture medium of mineralizing primary human osteoblasts
derived from three independent donors over the course of 1,
2, and 3 weeks. Temporal differences in total protein content
were observed with a significant (p < 0.05) decline in protein
concentration detected during the final week of mineralization
(Figure 2A). Nanoparticle tracking analysis (NTA) was applied
to determine how total protein content related to total particle
number (Figure 2B). In alignment with protein concentration,
the number of particles isolated was found to decrease in mature
cultures, with a significant (p < 0.05) decline in particle number
observed between weeks 2 (2.05× 109) and 3 (1.12× 109). These
findings may suggest that most of the protein was associated
with vesicles with limited indication of the presence of non-
vesicular proteins. The presence of sEVs at each time point
was visually confirmed using transmission electron microscopy
(TEM) (Figure 2C and Supplementary Image 1). Differences in
vesicle morphology were noted, with vesicles isolated during
week 3 displaying a less organized structure and visual evidence
of rupture which is perhaps indicative of a decline in membrane
integrity and the release of luminal content (Figure 2C). Particles
from all three isolations featured an electron dense core, which
appeared to become more organized at week 2. Particle size
measurement was achieved using dynamic light scattering (DLS)
and indicated a bimodal size distribution over the course of
osteoblast differentiation (Figures 2D). Particle polydispersity
decreased over time and bimodality become increasingly evident
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FIGURE 1 | Characterization and differentiation of human primary osteoblasts derived from three separate donors toward a mineralizing phenotype over a period of
21 days. (A) Gene expression profiling of primary human osteoblasts showed upregulation of four osteogenic markers. (B) Differentiation of osteoblasts cultures in the
presence of growth medium (GM) and mineralization medium (MM) containing 10 nM β-glycerophosphate and 50µg/mL L-ascorbic acid over a period of 7, 14, and
21 days induced extracellular matrix mineralization, which was visualized using Alizarin red calcium stain. (C) Visual differences in mineralization observed using
Alizarin red were confirmed semi-quantitatively. (D) The concentration of Alkaline phosphatase (ALP) was calculated per cell. Significant increases in ALP
concentration were observed at days 7 and 14. Scale bars = 15mm, *p ≤ 0.05. N = 3.
with peaks becoming increasingly distinct as mineralization
advanced. At week 3 (330 nm) maximum particle size decreased
relative to weeks 1 and 2 (>500 nm). Weighted averages
calculated for particles showed no statistical change over the
course of 3 weeks, with mean sizes of 124, 144, and 112 nm,
respectively (Figure 2E).
We next applied nano-liquid chromatography-tandem
mass spectrometry (LC-MS/MS) to determine how the total
number of proteins associated with osteoblast sEVs changed as
mineralization advanced and the extracellular matrix became
demonstrably more calcified (Figure 3A). Our data revealed
the presence of 310 (week 1), 292 (week 2), and 281 (week 3)
proteins, respectively (Figure 3B). A total of 249 proteins were
shared throughout the 21-day culture period. 77 proteins were
found to be exclusively localized to sEVs isolated at different time
points during osteoblast differentiation, with 25 identified at
week 1, 7 at week 2, and 45 at week 3. Analysis of relative protein
intensity revealed a 79% correlation in MS peak measurements
between 269 common proteins at weeks 1 and 2 (Figure 3Ci).
This trend declined as mineralization progressed, with 60%
correlation in the intensity of proteins co-expressed at weeks 2
and 3 (Figure 3Cii), while only a 46% correlation was observed
between weeks 1 and 3 (Figure 3Ciii).
We next sought to identify proteins that were most
differentially regulated in sEVs throughout the course of
mineralization and identify whether these changes were distinct
between weeks 1, 2, and 3. To visualize global proteomic
changes for secreted osteoblast EVs across the 3-week period,
a principal component analysis (PCA) of total protein intensity
was applied. PCA highlighted a clear spatial distinction between
MS protein spectra collected at each time point (Figure 4A). To
further understand the proteins that demonstrated the greatest
discriminatory power between time points, multiple orthogonal
partial least squares-discriminant (OPLS-DA) analyses were
performed (i.e., weeks 1v2, 1v3, 2v3). Separation of time
points was seen in all 2-dimensional score plots corresponding
to OPLS-DA analyses (data not shown) and S-plots were
consulted for the up- and down-regulated proteins that had
the greatest influence on the multivariate model (Figure 4B).
Volcano plots were generated to identify vesicle-associated
proteins that were significantly upregulated at early, intermediate
and mature phases of osteoblast differentiation (Figure 4C).
Only proteins with a Log2 fold change of >1 and a p <
0.05 were considered to be statistically significant. Analysis
revealed that relatively few significant differences could be
observed between the relative protein profiles of vesicles
isolated at week 1 and 2 (Figure 4Ci). 17 proteins were found
to be significantly upregulated between these two isolations,
with 4 upregulated at week 2 (blue: S100A6, PLEC, ANPEP,
CHI3L1) and 13 upregulated at week 1 (green: CD81, FBN2,
NID2, RELN, NUTF2, THBS1, LGALSL, MFGE8, COL4A1,
COL5A2, COL16A1, PCOLCE2, ADK, MYH9, FBN1, HSPG2).
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As primary osteoblasts differentiated and generated amineralized
matrix the number of differentially expressed proteins increased
significantly, with 75 and 73 proteins significantly upregulated
between vesicles isolated at weeks 2 and 3 (12 at week 2, 63
at week 3), and weeks 1 and 3 (26 at week 1, 47 at week 3),
respectively (Figure 4Cii,iii). When including proteins exclusive
to week 3 vesicles, a total of 116 were found to be differentially
upregulated. Of these, 65 proteins were non-exclusively up-
regulated, 22 were up-regulated relative to week 1 and 29 relative
to week 2. Comprehensive details of these proteins can be found
in Table 2.
Data outlined in Figures 3, 4 demonstrated much of the
significant changes in sEV protein content occurred at week 3,
when mineralization was most advanced. Few changes in protein
intensity were observed between weeks 1 and 2 (79% Pearson
correlation). As such, we carried out gene ontology (GO) analysis
using the PANTHER (protein annotation through evolutionary
relationship) classification system to identify differences in
predicted biological function, molecular mechanism and cellular
compartment of proteins upregulated at 3. Based on our
stringent exclusion criteria, a total of 116 proteins were
found to be upregulated or exclusive to vesicles isolated
during the third week of osteogenic differentiation. Of these
116 proteins 56% were non-specifically upregulated relative
to vesicles isolated at both week 1 and 2. GO analysis of
biological process revealed overlapping functions in extracellular
matrix organization and cell adhesion, with both processes
particularly upregulated at week 3 when compared with week 2
(Figure 5A). In addition, proteins identified in sEVs at week 3
aligned with cartilage and skeletal system development. Again,
these differences were particularly evident when compared with
vesicles derived at week 2.Molecular mechanisms associated with
these proteins correlated with the binding of lipids, calcium and
glycosaminoglycans (Figure 5B). These proteins were predicted
to localize within the extracellularmatrix and a higher proportion
of these proteins derived from the endoplasmic reticulum
(Figure 5C).
DISCUSSION
We have previously shown that osteoblasts secrete mineralizing
sEVs into the culture medium and that administration of these
particles within MSC cultures is able to enhance differentiation
(Davies et al., 2017). The outcomes of this study contribute
further insight on how howthe morphology and biological
content of these complex nanoparticles changes as mineralization
advances (Xiao et al., 2007; Morhayim et al., 2015). This
could have considerable implications relating to the prospective
application of sEVs in regenerative medicine as well as the
reproducibility of research findings between studies. In the
present study we isolated sEVs from the culture media of
mineralizing primary osteoblasts over a period of 21 days under
chemically-defined conditions. We identified the presence of
sEVs during early (week 1), mid (week 2), and late (week
3) matrix mineralization and noted a significant reduction
in particle concentration at week 3. At each time point we
observed a consistent bimodal size distribution indicative of a
heterogeneous population of microvesicle-like (100–1000 nm),
as well as exosome-like (30–150 nm) particles (Raposo and
Stoorvogel, 2013). As osteoblast differentiation advanced EVs
became less polydisperse, with the presence of two distinct
populations becoming more apparent. When visualized using
TEM, morphological differences were evident between vesicles
generated during early (week 1) and terminal (week 3)
stages of osteoblast differentiation, with visual indications
of compromised structural integrity evident during week 3.
This is likely related to the progressive formation of mineral
crystals previously shown to radially bud and perforate the
vesicle membrane (Eanes, 1992; Skrtic and Eanes, 1992). These
growing crystals associate with the surrounding osteoid to form
mineralized nodules that propagate along an external collagen
template (Hasegawa et al., 2017). Such findings align with
observations reported in a model of rat tibial regeneration, where
evidence of vesicle rupture was reported following 21 days, in
line with proximity to the calcified front (Sela et al., 1992).
Deformation of these vesicles may also account for the significant
reduction in particle number detected at week 3 and the distinct
absence of particles over 330 nm in size, whichmay have ruptured
(Amir et al., 1988). The absence of a visually distinctive plasma
membrane is likely to be related to the commercial method of
precipitation applied to isolate the vesicles (Martins et al., 2018).
In addition to morphological variations in vesicle profiles, we
were able to identify a correlation between total sEV protein
number and osteoblast differentiation status, as indicated by a
declining Pearson correlation coefficient of 0.79 (week 1 vs. 2),
0.60 (week 2 vs. 3), and 0.46 (week 1 vs. 3). Gene ontology analysis
highlighted the significant differences in protein expression at
week 3 correlated with an enrichment in extracellular, vesicular
and membrane-bound proteins with biological functions in
extracellular matrix organization, angiogenesis, and skeletal
development. These results contribute evidence to demonstrate
osteoblast sEVs are dynamic units that have temporally defined
roles in matrix development. To date, relatively few studies have
analyzed the sEV proteome. The first study to do so compared
vesicles isolated from culture medium using ultracentrifugation
with matrix vesicles embedded in the extracellular matrix. In
this study the 544 proteins were identified in sEVs isolated from
immortalized mineralizing MC3T3-E1 cells, whereas the present
study documented only 249 common proteins among sEVs
isolated over a period of 3 weeks. However, a number of common
extracellular matrix proteins (Emilin-1, MMP-2, Periostin,
Thrombospondins, and Decorin), enzymes (Aminopeptidase-N,
superoxide dismutase and Cathepsin proteins) and membrane
proteins (Integrins αV and β3) are common to sEVs isolated
in both studies. Further correlation exists in the presence
of cytoskeletal (α-actinin-1 and−4, Vinculin and Gelsolin),
signaling (GTP-binding proteins, 14-3-3 proteins and Rab
family proteins) and calcium regulating (Annexin and S100
proteins) proteins (Xiao et al., 2007). The second study applied
ultracentrifugation to isolate sEVs from the culture medium
of mineralizing human SV-HFO fetal pre-osteoblast cells and,
to our knowledge, is the only other study to have profiled
sEVs over the course of mineralization (Morhayim et al., 2015).
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FIGURE 2 | Comparison of sEVs released by mineralising primary osteoblasts derived from three separate donors into culture medium over a period of 21 days.
Three repeats were performed for each donor. EVs were isolated during the first, second, and third week of differentiation and (A) total protein and (B) particle number
quantified. (C) sEVs were visualized using TEM. Changes in sEV morphology were apparent, with visual indications of rupture evident during week 3. (D) Relative sEV
diameter was assessed using dynamic light scattering (DLS) (E) Median peak intensities and weighted averages for sEVs isolated at each time point. Scale bars =
50 nm, *p ≤ 0.05. N = 3.
Morhayim et al. identified a total of 1116 proteins, a number of
which represented osteoblast-related proteins linked to skeletal
development, differentiation and calcium ion binding. These
included a number (30%) of osteoblast-EV specific proteins,
which were not observed in our own study. Variations observed
in total protein content observed between studies are likely
manifold, with differences in cell type and sEV isolation
procedure and time of isolation being perhaps most significant.
However, the robustness of our approach is demonstrated
by the identification of common annexin (ANXA2, ANXA6),
tetraspanin (CD81) and metabolic (GAPDH, LDHA) vesicle
markers (Morhayim et al., 2015). Further, EVs isolated in the
present study contained 60% of the most 100 most prevalent
EV proteins as published by Vesiclepedia (http://microvesicles.
org/extracellular_vesicle_markers). Perhaps most interestingly,
in line with the findings of Morhayim et al. we provide evidence
through gene ontology analysis to indicate that bone-related
processes are one of several primary functions of sEVs.
In addition to the protein signature of sEVs,time
dependent changes in the lipid profile have been previously
demonstrated. These findings were described in a rodent
model of endosteal repair, where variations in phospholipids,
including phosphotidylcholine (PC), phosphotidylserine (PS)
and sphingosine were found to correlate with the stage of
regeneration (Schwartz et al., 1989). Since the organization of
phospholipids within the EV membrane is critical for driving
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FIGURE 3 | Analysis of differentially expressed proteins localized to osteoblast sEVs identified using LC-MS/MS. sEVs were isolated from three separate donors with
three repeats performed for each donor. (A) Schematic representation of the relationship between sEVs in relation to the maturity and organization of the mineralized
matrix. (B) Venn diagram depicting specific and non-specific proteins localized to sEVs isolated during 1, 2- and 3-weeks mineralization. (C) MS peak intensity plots
comparing -Log10 MS-peak intensities of proteins associated with sEVs during weeks 1 (i), 2 (ii), and 3 (iii) of differentiation and their associated Pearson’s correlation
values. N = 3.
mineral formation via the NCC, variations in content will
inevitably influence protein interactions that could impact the
nucleational capacity of vesicles and their association with the
extracellular matrix. However, to our knowledge, no study has
yet profiled changes in the protein content of osteoblast-derived
vesicles during the course of mineralization. Central to the
NCC is the annexin family of calcium regulated phospholipid-
binding proteins, which localize to the vesicle lumen, outer
surface and inner leaflet. Members of the annexin family are
proposed to associate with Ca2+, inorganic phosphate (Pi) and
PS to configure an optimal environment for the nucleation of
mineral crystals. It is hypothesized that this interaction drives
the transition of amorphous calcium phosphate through a series
of intermediate phases to generate thermodynamically stable
hydroxyapatite crystals (Anderson, 1995). However, annexin
proteins are also likely to have additional roles in the binding
and channeling of calcium ions. We have previously shown
that annexin proteins I, II and VI are significantly upregulated
in mineralizing sEVs derived from the culture medium of
mineralizing osteoblasts (Davies et al., 2017). The pro-osteogenic
effects of these proteins has been further demonstrated in
synthetic models of the NCC, where the incorporation of
Annexin-A5 promoted a significant increase the rate and total
amount of mineral formed when incubated with synthetic
cartilage lymph (Genge et al., 2007). In the present study we
provide evidence to indicate a temporal relationship between the
profile of annexins and the osteoblast maturity, with annexin-
A2, -A5 and -A6 significantly upregulated in sEVs during
the third week of osteoblast differentiation, where significant
mineralization was evident (Figure 1). Such variation in proteins
either directly or indirectly associated with the NCC will have
implications when considering the potential application of
osteoblast-derived vesicles for regenerative applications, where
it will be therapeutically advantageous to select for the most
osteo-inductively potent particles (Bjørge et al., 2018).
Temporal differences in annexin proteins also reflect
biochemical changes in the composition of the developing
ECM indicative of maturation that are, at least in part, related
to collagen composition. It has been proposed the collagen-
interacting properties of vesicles may function to align them
within the matrix and provide a template for mineralization
(Bottini et al., 2018). For instance, Annexin A2 mediates the
secretion of collagen type-VI (Dassah et al., 2014), which
functions by bridging cells with the surrounding connective
tissue and organizing the three-dimensional architecture of bone
(Cescon et al., 2015). In the present study we show that type-VI
collagen was significantly upregulated in sEVs during the third
week of mineralization in vitro, thus supporting findings by
Lamandé et al. (2006) demonstrating the formation of stable
collagen-VI helices by a SaOS-2 osteosarcoma cell line occurs
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FIGURE 4 | Comparative analysis of proteins localized to osteoblast sEVs during matrix mineralization. (A) Principal component analysis of total protein intensity. (B)
Multiple orthogonal partial least squares-discriminant (OPLS-DA) analysis of between-group differences in MS protein intensity to identify differentially expressed
proteins between sEVs isolated from the culture medium of mineralising osteoblasts at weeks 1, 2, and 3. Discriminatory proteins identified between (Bi) weeks 1 and
2 included 1, plectin; 2, galectin; CD59 glycoprotein; 4, aminopeptidase N; 5, chitinase-3-like protein 1; 6, collagen alpha-1 XVI chain; CD81 antigen; (Bii) weeks 2
and 3: 1, glia-derived nexin; 2, annexin A6; 3, ApoE; 4, protein transport protein Sec23A; 5, AP-2 complex subunit alpha-1/2; and (Biii) weeks 1 and 3: 1, plectin; 2,
translational endoplasmic reticulum ATPase; 3, Annexin A6; 4, inactive serine protease PAMR1; 5, protein transport protein Sec23A; 6, reticulocalbin-3; 7,
endoplasmin. (C) Volcano plots displaying Log2 values for protein fold-change against Log10 false discovery rate (FDR). Only proteins with a Log2 fold change of >1
and a p < 0.05 were considered to be statistically significant.
later in the differentiation pathway (Lamandé et al., 2006).
Additional collagen subtypes, including type-I collagen were
found to be associated with vesicles but did not vary over the
course of mineralization. Annexin A2 and A6, which were also
found to be upregulated at week 3, are known to interact with
chondroitin sulfate, a structural component of cartilage and an
important mediator in bone regeneration, in a Ca2+-dependent
manner (Ishitsuka et al., 1998; Takagi et al., 2002). While the
interaction between annexin A6 and protein kinase C α has been
shown to mediate terminal differentiation and mineralization
events of hypertrophic chondrocytes by channeling the influx
of Ca2+ ions (Minashima et al., 2012). As such, temporal
variations observed in annexins and their defined interactions
with collagens, which are fundamental to the development of the
mineralizing ECM, implicate sEVs as mediators of changes in the
ECM required for the transition between hypertrophic cartilage
and endochondral bone.
In addition to specific interactions with collagenous and
non-collagenous components of the ECM, vesicles function
in the transportation of collagens and matrix proteins from
the endoplasmic reticulum into the extracellular environment.
This is achieved through coupling with coat protein carriers,
which include COPII carriers such as Sec23a (Malhotra and
Erlmann, 2015). In the present study, the inner coat protein
Sec23a was found to be upregulated in vesicles during the third
week of mineralization, correlating with an enhanced presence
of collagen type-VI. Furthermore, COPII vesicles utilized for
the translocation of collagens into the ECM are typically
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FIGURE 5 | Gene ontology (GO) analysis of proteins identified as being differentially upregulated in sEVs isolated during the third week of osteoblast differentiation
relative to those isolated at weeks 1 (dashed line) and 2 (block color). A total of 116 proteins were identified, with 87 and 99 proteins found to be differentially
upregulated when compared with sEVs isolated at weeks 1 and 2, respectively. (A) Biological processes, (B) molecular mechanisms and (C) cellular component
predicted for proteins identified at week 3.
under 100 nm, which correlates with the smaller subpopulation
of particles identified in the present study (Weeks 1 and
2, 44 nm; Week 3, 54 nm – Figure 2D). Although we are
aware that further investigation will be required to delineate
the mechanisms by which sEVs deliver collagen subunits to
drive development of the ECM, we believe that our initial
findings are of important biological relevance and propose that
osteoblasts secrete distinct vesicle subsets with discrete roles
during osteogenesis. In addition to collagens, profiling vesicles
over the course of a three-week differentiation period revealed
the presence of additional proteins known to be localized within
the endoplasmic reticulum, including reticulocalbin, calumenin,
reticulocalbin-3, endoplasmin, and translational endoplasmic
reticulum ATPase. These findings provide further support to
the theory that at least a subset of osteoblast-derived vesicles
derive from the trans-Golgi network and are trafficked to the
plasma membrane via interaction with members of the Rab
family of small GTPases where they fuse and are released
into the extracellular environment (Stenbeck and Coxon, 2014).
Furthermore, the contribution of ER-associated vesicles appears
to be dependent on the differentiation status of the osteoblast,
with proteins such as reticulocalbin, endoplasmin and calumenin
largely down-regulated during the third week of mineralization.
Further to the capacity of Annexin A2 tomediate the secretion
of collagen type-VI, this calcium-binding protein also interacts
with the Wnt signaling pathway inhibitor sclerostin, which has
led to the suggestion that this protein may function in the
regulation of osteogenesis (Devarajan-Ketha et al., 2012). The
Wnt family of secreted glycoproteins is critical for regulating
bone homeostasis through β-catenin-dependent canonical and
β-catenin independent non-canonical pathways. In the present
study we identified the presence of Wnt5a and the Wnt-1-
inducible signaling pathway protein (WISP-2) in sEVs and
documented significant upregulation during the third week of
mineralization (Table 1), when a calcified ECM was evident
(Figure 1). WISP-2 has previously been shown to promote
cell adhesion and differentiation depending on whether it is
secreted or localized within the cytoplasm (Grünberg et al., 2014).
However, the precise function of this protein in bone tissue is
far less well-understood than its sister protein, WISP-1, which
has well-documented roles in osteogenic differentiation and
bone repair (Maiese, 2016). Wnt5a functions in the regulation
of non-canonical Wnt signaling with a well-established role
in coordinating osteoclastogenesis through receptor tyrosine
kinase-like orphan receptor 2 (Ror2)/ c-Jun N-terminal kinase
signaling (Hasegawa et al., 2017). The Wnt5a ligand has also
been implicated in the onset of pathological vascular calcification
via its interaction with low density lipoprotein receptor-related
protein-1 (Woldt et al., 2012). Homozygous deletion of Wnt5a
has been shown to reduce the expression of critical pro-
osteogenic genes such as ALP, osterix and osteocalcin, as well
as the formation of mineralized nodules (Okamoto et al., 2014).
Previous research has identified vesicles as vehicles for the
systemic delivery of hydrophobic Wnt proteins in a diverse
range of cell types including human umbilical cord MSCs
(Zhang et al., 2015), cortical neurons (Tassew et al., 2017) and
macrophages (Menck et al., 2013). However, to our knowledge,
no previous studies have acknowledged the presence of these
critical homeostatic proteins in sEVs. As such, we present initial
findings to suggest that sEVs may function in the activation
of non-canonical Wnt signaling required for osteoclastogenesis
and the maintenance of bone homeostasis. However, additional
studies will be required to confirm this hypothesis.
CONCLUSIONS
Findings from the present study demonstrate that the
secretion of osteoblast vesicles is a dynamic and temporal
process, which is dependent on the mineralization status
of the ECM. sEVs contained many proteins implicated in
the nucleation and propagation of mineral in developing
hard tissues and shared common morphological and
biological features reported for matrix-bound vesicles. The
localization of osteogenic signaling proteins and postulated
components of the NCC increased as mineralization advanced.
Of significance was the upregulation of annexin family
members and Wnt signaling proteins in sEVs generated
during week 3, since these proteins have defined roles
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in osteogenesis. Our findings shed light on fundamental
mechanisms governing vesicle-mediated mineralization,
identifying it as a dynamic process whereby progressive
variations in sEV morphology and protein content mirror
developmental changes matrix organization. Findings also have
implications when considering the selection and application
of osteoblast-derived sEVs in regenerative medicine and
further studies will be required to determine the pro-
osteogenic properties of temporally isolated sEV fractions
when administered in vivo.
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